Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stem-Cell-Derived Extracellular Vesicles: Unlocking New Possibilities for Treating Diminished Ovarian Reserve and Premature Ovarian Insufficiency. | Life (Basel) | 2023 | 38137848 | PubTator, text mining | PubMed |
| Lambda CI Binding to Related Phage Operator Sequences Validates Alignment Algorithm and Highlights the Importance of Overlooked Bonds. | Genes (Basel) | 2023 | 38137043 | PubTator, text mining | PubMed |
| LLGL2 Inhibits Ovarian Cancer Metastasis by Regulating Cytoskeleton Remodeling via ACTN1. | Cancers (Basel) | 2023 | 38136424 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. | Clin Transl Med | 2023 | 38115703 | PubTator, text mining | PubMed |
| BLCA prognostic model creation and validation based on immune gene-metabolic gene combination. | Discov Oncol | 2023 | 38103068 | PubTator, text mining | PubMed |
| Profibrotic role of transcription factor SP1 in cross-talk between fibroblasts and M2 macrophages. | iScience | 2023 | 38094246 | PubTator, text mining | PubMed |
| Differential molecular profiles and associated functionalities characterize connective tissue grafts obtained at different locations and depths in the human palate. | Int J Oral Sci | 2023 | 38072943 | PubTator, text mining | PubMed |
| The Research Progress in Transforming Growth Factor-β2. | Cells | 2023 | 38067167 | PubTator, text mining | PubMed |
| Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. | Respir Res | 2023 | 38057814 | PubTator, text mining | PubMed |
| Double-edged role of mechanical stimuli and underlying mechanisms in cartilage tissue engineering. | Front Bioeng Biotechnol | 2023 | 38053849 | PubTator, text mining | PubMed |
| The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4-related disease. | Clin Transl Immunology | 2023 | 38034079 | PubTator, text mining | PubMed |
| The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. | Front Endocrinol (Lausanne) | 2023 | 38027131 | PubTator, text mining | PubMed |
| Relationship Between Retinal Layer Thickness and Genetic Susceptibility to Age-Related Macular Degeneration in Asian Populations. | Ophthalmol Sci | 2023 | 38025159 | PubTator, text mining | PubMed |
| An overview of recent treatment options for primary sclerosing cholangitis. | Ann Gastroenterol | 2023 | 38023975 | PubTator, text mining | PubMed |
| Prospective therapeutics for intestinal and hepatic fibrosis. | Bioeng Transl Med | 2023 | 38023697 | PubTator, text mining | PubMed |
| Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. | J Pharm Pharm Sci | 2023 | 38022905 | PubTator, text mining | PubMed |
| Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38022729 | PubTator, text mining | PubMed |
| Alport Syndrome: A Comprehensive Review. | Cureus | 2023 | 38021591 | PubTator, text mining | PubMed |
| Mechanobiology in oncology: basic concepts and clinical prospects. | Front Cell Dev Biol | 2023 | 38020912 | PubTator, text mining | PubMed |
| Decellularized diseased tissues: current state-of-the-art and future directions. | MedComm (2020) | 2023 | 38020712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=12